Search
-
Consensus definitions in imported human schistosomiasis: a GeoSentinel and TropNet Delphi study
(The Lancet Infectious Diseases, 2024-03-08)Article de revue -
Assessment of adherence to the 2020 Surviving Sepsis Campaign guidelines for fluid resuscitation in children with suspected septic shock in paediatric emergency departments: a prospective multicentre study
(Archives of Disease in Childhood, 2024-03-18)Article de revue -
Social and clinical vulnerability in stroke and STEMI management during the COVID-19 pandemic: a registry-based study
(BMJ Open. vol. 14, n° 1, pp. e073933, 2024-01-03)Article de revueOpen access -
Post-clustering difference testing: valid inference and practical considerations
(Computational Statistics and Data Analysis)Article de revueOpen access -
Statistical classification of treatment responses in mouse clinical trials for stratified medicine in oncology drug discovery
(Scientific Reports. vol. 14, n° 1, pp. 934, 2024-01-09)Article de revueOpen access -
High Amino Acid Intake in Early Life Is Associated With Systolic but Not Diastolic Arterial Hypertension at 5 Years of Age in Children Born Very Preterm
(Journal of the American Heart Association. vol. 13, n° 1, pp. e032804, 2024-01-02)Article de revueOpen access -
XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration
(Ophthalmology and Therapy. vol. 13, n° 3, pp. 725-738, 2024-03-01)Article de revueOpen access -
Efficacity and Safety of the Fluocinolone Acetonide Implant in Uveitic Macular Edema: A Real-Life Study from the French Uveitis Network
(Journal of Personalized Medicine. vol. 14, n° 3, 2024-02-24)Article de revueOpen access -
Perceptions, facilitators and barriers to the implementation of interpersonal group therapy to treat depression among people living with HIV in Senegal: a qualitative study
(Frontiers in Public Health. vol. 12, pp. 1295181, 2024-01-01)Article de revueOpen access -
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial
(Journal of Infection. vol. 88, n° 3, pp. 106120, 2024-02-16)Article de revueOpen access